Adenovirus-Mediated p53 Growth Inhibition of Ovarian Cancer Cells Is Independent of Endogenous p53 Status

By Wolf J.K.   Mills G.B.   Bazzet L.   Bast R.C.   Roth J.A.   Gershenson D.M.  

Gynecologic Oncology, Vol. 75, Iss. 2, 1999-11 ,pp. : 261-266

Elsevier

Access to resources Recommend Favorite

Synergistic cytotoxic effects of recombinant human adenovirus p53 and radiation at various time points in A549 lung adenocarcinoma cells

By              

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 529-533

Spandidos Publications

Access to resources Recommend Favorite

Growth Suppression of Human Ovarian Cancer Cell Lines by the Introduction of a p16 Gene via a Recombinant Adenovirus

By Wolf J.K.   Kim T.-E.   Fightmaster D.   Bodurka D.   Gershenson D.M.   Mills G.   Wharton J.T.  

Gynecologic Oncology, Vol. 73, Iss. 1, 1999-04 ,pp. : 27-34

Elsevier

Access to resources Recommend Favorite

In vivo comparison of transduction efficiency with recombinant adenovirus-mediated p53 in a human colon cancer mouse model by different delivery routes

By Xie Qi  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 12, 2008-12 ,pp. : 704-708

Springer Publishing Company

Access to resources Recommend Favorite

Clinical study of recombinant adenovirus- p 53 (Ad p 53) combined with hyperthermia in advanced cancer (a report of 15 cases)

By Zhang S.   Xu G.   Liu C.   Xiao S.   Sun Y.   Su X.   Cai Y.   Li D.   Xu B.  

International Journal of Hyperthermia, Vol. 21, Iss. 7, 2005-11 ,pp. : 631-636

Informa Healthcare

Access to resources Recommend Favorite